Silence Therapeutics Is Maintained at Overweight by Morgan Stanley

(18:07 GMT) Silence Therapeutics Price Target Cut to $25.00/Share From $67.00 by BMO Capital

European equities traded in the US as American depositary receipts fell late Tuesday morning with the S&P Europe Select ADR Index down 0.75% to 1,409.96

From continental Europe, the gainers were led by consumer goods giant Unilever (UL) and pharmaceutical company Sanofi (SNY), which rose 2.3% and 1.9% respectively. They were followed by brewing company Anheuser-Busch InBev and medical device maker EDAP TMS , which were up 1.4% and 0.4% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech E and semiconductor company Sequans Communications , which lost 5.6% and 4.9% respectively. They were followed by financial services company Banco Santander and biopharmaceutical company DBV Technologies , which dropped 4.4% and 4.3% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical companies Silence Therapeutics and GSK , which increased 3% and 2.9% respectively. They were followed by educational publisher Pearson and biotech company Autolus Therapeutics , which advanced 2.5% and 1.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm and construction materials supplier CRH , which fell 9.6% and 6.4% respectively. They were followed by cruise line operator Carnival and biopharmaceutical company NuCana , which were down 5.9% and 3.1% respectively.

(14:43 GMT) Silence Therapeutics Price Target Cut to $4.00/Share From $6.00 by Goldman Sachs

European equities traded in the US as American depositary receipts were moving higher late Friday morning, up 0.48% to 1,412.34 on the S&P Europe Select ADR Index, which is relatively flat for the week.

From continental Europe, the gainers were led by internet browser company Opera and biopharmaceutical company Genfit , which rose 6.8% and 2.5%, respectively. They were followed by 3D printer company Materialise and biotech firm BioNTech , which were up 2.4% and 1.4%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies and biotech firm Evaxion Biotech E, which fell 7.8% and 5.1%, respectively. They were followed by biopharmaceutical company Cellectis and oil and gas company Eni , which were down 1.5% and 1.3%, respectively.

From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo and financial services company Barclays , which increased 2% each. They were followed by financial services company HSBC and cruise line operator Carnival , which were up 1.5% each.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics and pharmaceutical company Silence Therapeutics , which dropped 4.1% and 3.7%, respectively. They were followed by biotech firm Autolus Therapeutics and biopharmaceutical company TC Biopharm , which lost 3.1% and 2.8%, respectively.

European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.49% to 1,416.32 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet browser company Opera and biopharmaceutical company Grifols , which rose 6% and 5.7% respectively. They were followed by biopharmaceutical company argenx and brewing company Anheuser-Busch InBev , which increased 4.3% and 1.9% respectively.

The decliners from continental Europe were led by electronics conglomerate Philips and 3D printer company Materialise , which lost 2.3% and 2.1% respectively. They were followed by software firm SAP and oil and gas company Eni , which fell 2% and 1.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics and Verona Pharma , which climbed 12% and 7% respectively. They were followed by pharmaceutical company Silence Therapeutics and biopharmaceutical company Mereo BioPharma Group , which were up 4.7% and 2.2% respectively.

The decliners from the UK and Ireland were led by communications company WPP and biotech firm Trinity Biotech , which shed 16% and 2.5% respectively. They were followed by utilities company National Grid and alcoholic beverage company Diageo , which dropped 1.6% and 1.2% respectively.